Answers are grounded in this paper and cite their sources.
Analysis reveals risk factor clusters significantly impact comorbidity rates, pointing to effective treatment pathways.
The problem of comorbidity is of great importance due to its severe medical and social consequences. In the etiopathogenesis of comorbid pathology in patients with somatic disease, a significant role is played by risk factors that tend to appear in the form of clusters. Aim of the study was to investigate the features of the severity and structure of comorbidity in patients with a therapeutic profile in the presence of each of the three clusters of risk factors for chronic non-communicable diseases (cluster 1: age over 52 years, obesity, hyperglycemia; cluster 2: arterial hypertension, hypertriglyceridemia, elevated serum concentration of C-reactive protein (CRP), hyperuricemia; cluster 3: low(LDL) and high-density lipoprotein (HDL) hypocholesterolemia). Material and methods. The study included data from case histories of 4908 people, 2026 men (41.3 %) and 2882 women (58.7 %), aged 57.9 ± 0.2 years (arithmetic mean ± standard error of the mean). Three groups of patients were formed depending on the presence of a particular cluster of risk factors: Group 1 – age over 52 years, obesity, hyperglycemia ( n = 434); Group 2 – arterial hypertension, hypertriglyceridemia, elevated serum concentration of CRP, hyperuricemia ( n = 108); Group 3 – LDL hypercholesterolemia, HDL hypocholesterolemia ( n = 363). The frequency of all available nosological forms was analyzed in accordance with ICD-10. Transnosological comorbidity was assessed by the number of nosological forms, transsystemic comorbidity – by the number of ICD-10 classes in one patient. Results and discussion. A high level of transsystemic and transnosological comorbidity was revealed in patients with any of the considered clusters, which emphasizes their importance in the development of comorbidity. The highest comorbidity rates were found in patients with a cluster of factors: age over 52 years, obesity and hyperglycemia (transnosological comorbidity – 8.86 ± 0.19; transsystemic comorbidity – 4.60 ± 0.06). The most common nosologies in patients in all 3 groups were hypertension, deforming dorsopathy and non-alcoholic fatty liver disease, which may be due to the common pathogenetic mechanisms of these diseases (dysregulatory, vascular and metabolic disorders), which can be initiated by the considered risk factors. Conclusions. Among the clusters of factors associated with comorbidity, the most significant are the following: age over 52 years, obesity, hyperglycemia; arterial hypertension, hypertriglyceridemia, hyperuricemia, increased serum concentration of CRP.
No takes yet. Share an insight, caveat, or question.
Sevostyanova et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: